| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 31-Dec-08 | | Total Revenue | 5,569,000 | 5,909,000 | 5,050,000 | 5,237,000 | | Cost of Revenue | 3,404,000 | 3,646,000 | 3,173,000 | 3,297,000 | | | Gross Profit | 2,165,000 | 2,263,000 | 1,877,000 | 1,940,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,701,000 | 1,714,000 | 1,636,000 | 1,703,000 | | Non Recurring |
-
|
-
|
-
| 2,346,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 464,000 | 549,000 | 241,000 | (2,109,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,000 | 4,000 | 1,000 | (7,000) | | Earnings Before Interest And Taxes | 466,000 | 553,000 | 242,000 | (2,116,000) | | Interest Expense | 140,000 | 145,000 | 156,000 | 153,000 | | Income Before Tax | 326,000 | 408,000 | 86,000 | (2,269,000) | | Income Tax Expense | 79,000 | 95,000 | 25,000 | (819,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 247,000 | 313,000 | 61,000 | (1,450,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 247,000 | 313,000 | 61,000 | (1,450,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $247,000 | $313,000 | $61,000 | ($1,450,000) |
|
0.29% Nasdaq 
Income Statement
